(+)-12alpha-Hydroxysophocarpine

Details

Top
Internal ID 06af5cb7-aa32-4ca0-b36f-fad2380b3e82
Taxonomy Alkaloids and derivatives > Lupin alkaloids > Matrine alkaloids
IUPAC Name (1S,2S,3S,9S,17S)-3-hydroxy-7,13-diazatetracyclo[7.7.1.02,7.013,17]heptadec-4-en-6-one
SMILES (Canonical) C1CC2CN3C(C4C2N(C1)CCC4)C(C=CC3=O)O
SMILES (Isomeric) C1C[C@H]2CN3[C@@H]([C@@H]4[C@H]2N(C1)CCC4)[C@H](C=CC3=O)O
InChI InChI=1S/C15H22N2O2/c18-12-5-6-13(19)17-9-10-3-1-7-16-8-2-4-11(14(10)16)15(12)17/h5-6,10-12,14-15,18H,1-4,7-9H2/t10-,11-,12-,14-,15-/m0/s1
InChI Key RAGVUCIHXGJGEQ-YLXLXVFQSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22N2O2
Molecular Weight 262.35 g/mol
Exact Mass 262.168127949 g/mol
Topological Polar Surface Area (TPSA) 43.80 Ų
XlogP 0.60
Atomic LogP (AlogP) 0.62
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
CHEMBL441175
J3.497.995B

2D Structure

Top
2D Structure of (+)-12alpha-Hydroxysophocarpine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9681 96.81%
Caco-2 + 0.8614 86.14%
Blood Brain Barrier + 0.8444 84.44%
Human oral bioavailability + 0.6000 60.00%
Subcellular localzation Mitochondria 0.5686 56.86%
OATP2B1 inhibitior - 0.8605 86.05%
OATP1B1 inhibitior + 0.9065 90.65%
OATP1B3 inhibitior + 0.9524 95.24%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior + 0.7000 70.00%
BSEP inhibitior - 0.8933 89.33%
P-glycoprotein inhibitior - 0.9634 96.34%
P-glycoprotein substrate - 0.7642 76.42%
CYP3A4 substrate + 0.5575 55.75%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7741 77.41%
CYP3A4 inhibition - 0.9411 94.11%
CYP2C9 inhibition - 0.9160 91.60%
CYP2C19 inhibition - 0.8607 86.07%
CYP2D6 inhibition - 0.9257 92.57%
CYP1A2 inhibition - 0.8155 81.55%
CYP2C8 inhibition - 0.9665 96.65%
CYP inhibitory promiscuity - 0.8132 81.32%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6336 63.36%
Eye corrosion - 0.9697 96.97%
Eye irritation - 0.9018 90.18%
Skin irritation - 0.6559 65.59%
Skin corrosion - 0.8766 87.66%
Ames mutagenesis - 0.7500 75.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6170 61.70%
Micronuclear + 0.5700 57.00%
Hepatotoxicity + 0.7689 76.89%
skin sensitisation - 0.8802 88.02%
Respiratory toxicity + 0.7444 74.44%
Reproductive toxicity + 0.7111 71.11%
Mitochondrial toxicity + 0.8750 87.50%
Nephrotoxicity + 0.6339 63.39%
Acute Oral Toxicity (c) II 0.5105 51.05%
Estrogen receptor binding - 0.8425 84.25%
Androgen receptor binding - 0.6197 61.97%
Thyroid receptor binding - 0.6164 61.64%
Glucocorticoid receptor binding - 0.6208 62.08%
Aromatase binding - 0.9095 90.95%
PPAR gamma - 0.6771 67.71%
Honey bee toxicity - 0.9242 92.42%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity - 0.8731 87.31%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 96.30% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.95% 95.56%
CHEMBL253 P34972 Cannabinoid CB2 receptor 87.92% 97.25%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.84% 95.89%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 85.66% 93.03%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 85.40% 93.04%
CHEMBL2140 P48775 Tryptophan 2,3-dioxygenase 84.93% 98.46%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.89% 100.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 83.36% 90.71%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 82.75% 96.09%
CHEMBL1871 P10275 Androgen Receptor 82.28% 96.43%
CHEMBL3137262 O60341 LSD1/CoREST complex 82.03% 97.09%
CHEMBL1795139 Q8IU80 Transmembrane protease serine 6 81.45% 98.33%

Cross-Links

Top
PubChem 44408595
NPASS NPC144714
LOTUS LTS0194659
wikiData Q105232605